(Q44241698)

1 December 2017

title

Anti-MRSA cephems. Part 2: C-7 cinnamic acid derivatives (English)

1 reference

1 December 2017

Dane M Springer

1

1 reference

1 December 2017

Bing Yu Luh

series ordinal

2

1 reference

1 December 2017

Jason Goodrich

series ordinal

3

1 reference

1 December 2017

Joanne J Bronson

series ordinal

4

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

Bioorganic & Medicinal Chemistry

1 December 2017

published in

1 reference

1 December 2017

volume

11

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

265-279

1 reference

The progressive intercontinental spread of methicillin-resistant Staphylococcus aureus

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Discovery of RWJ-54428 (MC-02,479), a new cephalosporin active against resistant gram-positive bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

SAR studies of anti-MRSA non-zwitterionic 3-heteroarylthiocephems

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Studies on anti-MRSA parenteral cephalosporins. II. Synthesis and antibacterial activity of 7beta-[2-(5-amino-1,2,4- thiadiazol-3-yl)-2(Z)-alkoxyiminoacetamido]-3-(substituted imidaz.

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

CP6679, a new injectable cephalosporin. Part 1: synthesis and structure-activity relationships

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Novel cephalosporins 2. Synthesis of 3-heterocyclic-fused thiopyranylthiovinyl cephalosporins and antibacterial activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecalis

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Anti-MRSA cephems. Part 1: C-3 substituted thiopyridinium derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

The Vapor Phase Rearrangement of Thioncarbonates and Thioncarbamates

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

The Conversion of Phenols to Thiophenols via Dialkylthiocarbamates1

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

Structure-activity relationships of arylimidazopyridine cardiotonics: discovery and inotropic activity of 2-[2-methoxy-4-(methylsulfinyl)phenyl]-1H-imidazo[4,5-c]pyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0968-0896%2802%2900336-X

7 January 2021

10.1016/S0968-0896(02)00336-X

Identifiers

DOI

1 reference

1 December 2017

1 reference